Instituto de Investigación del Hospital de la Santa Creu i Sant Pau

Hospital de la Santa Creu i Sant Pau Research Institute

Information
C/ Sant Quintí, 77-79 08041 Barcelona

addictions, Alzheimer's, cancer, covid-19, embryonic development, diabetes, gene editing, cardiovascular diseases, neurodegenerative diseases, rare diseases, ageing, epidemiology, immunology, microbiology, neuroscience, mental health
Contact
Karla Islas Pieck
Press officer
kislas@santpau.cat
Tel. (34) 616 391 609

If you are the contact person for this centre and you wish to make any changes, please contact us.

SMC participants

Neurologist in the Neuromuscular Diseases Unit - Autoimmune Neurology - Neuromuscular Lab
Hospital de la Santa Creu i Sant Pau & Institut de Recerca Biomèdica Sant Pau, Barcelona

Principal Investigator, Lipid-Related Diseases Pathophysiology Group, Institut de Recerca Sant Pau (IR Sant Pau) and member of the CIBER on Diabetes and Associated Metabolic Diseases (CIBERDEM)

Contents related to this centre
blood

Researchers have found specific antibodies in the blood of patients years before they showed symptoms of multiple sclerosis. This group of antibodies was present in 10% of the 250 people who later developed the disease, and were part of a sample of over 10 million US military personnel. The finding could have potential for early detection of multiple sclerosis, says the research team in a paper published in Nature Medicine